
    
      Patients will receive one of three different doses of SBRT depending on which cohort they are
      in. The doses are:

      Cohort 1: 15 Gy (central tumors 10 Gy); Cohort 2: 20 Gy (central tumors 15 Gy); Cohort 3: 20
      Gy x 2 (central tumors 15 Gy x 2).

      In addition, all patients will receive three doses of MEDI6469. MEDI6469 is administered at
      0.4 mg/kg IV over 60 minutes using in-line filter on Days 1, 3, and 5.
    
  